News & Press Releases

Members Meredith Leary, David Adams, and Associate Sav Arguello co-authored an article in Law360 discussing the Financial Industry Regulatory Authority (FINRA)’s annual regulatory oversight report for 2024.

Fiduciary News spoke to Of Counsel Michelle Capezza in an article exploring the irony of taxing 401k plans to save social security in light of a recent report published by retirement researchers.

Member Cory Flashner spoke to the National Law Journal about a pivotal lawsuit brought by investor James Harper against the IRS, challenging the warrantless seizure of cryptocurrency records and questioning the third-party doctrine’s relevance to digital privacy at the 1st Circuit Court of Appeals. He explains the distinction in privacy expectations between crypto exchange data and cell phone records.

Mintz Members John Rudy and Matthew T. Simpson led the team that advised ArriVent Biopharma, Inc. on its initial public offering (IPO) on the Nasdaq Global Market. This was the second biotech IPO of 2024. ArriVent is a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics.

Podcaster Richard Hsu interviewed San Francisco Managing Member Steve Osborn on his podcast Hsu Untied. In the episode, Steve reflects on his career journey, including his start in law school to becoming an attorney advising on international work in London and Hong Kong, and his rise from launching a boutique firm to his current role as a tech and life sciences-focused Managing Member. Steve also highlights the importance of calculated risks for professional growth.

The Cigna Health Group signed a deal selling its Medicare businesses to Health Care Service Corporation (HCSC) for $3.7 billion. A Mintz team led by Tara Dwyer and Lauren Moldawer acted as regulatory counsel to The Cigna Group on the sale. In the deal, which is expected to close in the first quarter of 2025, HCSC will acquire Cigna’s Medicare lines including Medicare Advantage, Medicare supplement, and Medicare drug plans, as well as CareAllies, a unit that works with physician groups and other healthcare providers.